Colleen Smith, | |
2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462-1047 | |
(610) 834-1122 | |
Not Available |
Full Name | Colleen Smith |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 2250 Hickory Rd, Plymouth Meeting, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134307630 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SL006390L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Colleen Smith, 3970 Lancelot Pl, Phila, PA 19154-3513 Ph: (215) 637-0312 | Colleen Smith, 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462-1047 Ph: (610) 834-1122 |
News Archive
As more people return to indoor settings for work and school, new research shows stricter policy restrictions on business operations and indoor mask-wearing reduced COVID-19 cases in Ontario during the first and second waves.
Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking GleevecĀ® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.
Savient Pharmaceuticals, Inc. announced that new data presented in an oral session at the European League Against Rheumatism (EULAR) 2012 congress showed that patients with refractory chronic gout (RCG) who also suffer from chronic kidney disease (CKD) responded to treatment with KRYSTEXXA (pegloticase) regardless of baseline CKD stage.
The physicians of the American Academy of Pain Medicine (AAPM) hailed long-awaited labeling changes and other steps taken by the U.S. Food and Drug Administration (FDA) last week to enhance safety in the prescribing of extended-release and long-acting (ER/LA) opioids.
› Verified 8 days ago
Meredith B. Horne, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Cherie Levy Roche, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 | |
Burnetta Swartz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Mrs. Kristin Sears-kopp, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 | |
Ms. Vicki Lynn Meitus, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 502 W Germantown Pike, Suite 200, Plymouth Meeting, PA 19462 Phone: 610-825-9360 | |
Ann Elizabeth Bollenbach, MED CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Road, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 Fax: 610-834-7525 | |
Mrs. Mila Marie Capuano, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |